Abstract
Various human cancers express elevated levels of the receptor tyrosine kinases Met or Ron and v6-containing isoforms of CD44. The activation of Met and Ron requires the presence of such CD44 v6-containing isoforms that act as coreceptors. Three amino acids within the v6 sequence were identified by mutational analysis to be essential for the coreceptor function: EWQ in the rat sequence and RWH in human. Peptides comprising these three amino acids (the smallest containing only five amino acids) efficiently act as competitors and block ligand-dependent activation of Met or Ron and subsequent cell migration.
- Ron
- Met
- blocking peptides
- CD44
- cell scattering
Footnotes
- Received January 26, 2005.
- Revision received April 18, 2005.
- Accepted May 4, 2005.
- ©2005 American Association for Cancer Research.